Once-weekly Lilly diabetes drug wins EU approval
November 25, 2014 at 13:52 PM EST
Nov 25 (Reuters) - The European Commission has granted marketing approval to Eli Lilly and Co's injectable Trulicity treatment for adults with type 2 diabetes, the U.S. drugmaker said on Tuesday.
